Clinical trial
Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2…
NCT00471549 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00471549 |
|---|---|
| Title | Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes |
| Official title | Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria |
| Lead sponsor | University of Aarhus, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Statin (simvastatin) |
| Enrollment | 18 |
| Start date | Jun 1, 1991 |
| Completion | Dec 1, 1993 |
| First posted | May 10, 2007 |
| Last update posted | May 10, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: